FolioLanternBeta
MDGLMadrigal Pharmaceuticals, Inc.

David Soergel

Chief Medical Officer at Madrigal Pharmaceuticals, Inc., as of Jun 1, 2026Sold $952K of stock in the past 12 months: 54% under a disclosed plan and 46% to cover taxes.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
10K
shares held after the latest filing, Madrigal Pharmaceuticals, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
1.9K
shares sold, past 12 months
2
days with sales
$517K
largest single day, Jun 1, 2026
1
company filed for

Share of stake sold at Madrigal Pharmaceuticals, Inc. is not shown: most of their shares vested during the period, so a percentage would mislead. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMarAprMay 2026: $435K to cover taxesMayJun 2026: $517K under a disclosed plan$517KJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Madrigal Pharmaceuticals, Inc. (MDGL)Chief Medical OfficerMay 16, 2025Jun 1, 2026

Recent filings

The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.